- Associated Press•7 hours ago
On a per-share basis, the Bothell, Washington-based company said it had a loss of 23 cents. The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment ...
- Zacks•2 days ago
Medical stocks are once again expected be among the better performers in Q2. Johnson & Johnson (JNJ) and Biogen have already set the tone with beats and raised outlooks.
Seattle Genetics, Inc.NasdaqGS
After hours: 43.770.00 (0.00%) as of 5:18 PM EDT
|Bid||44.00 x 200|
|Ask||46.00 x 300|
|52wk Range||26.02 - 49.66|
|Day's Range||43.60 - 44.68|
|Avg Vol (3m)||862,026|
As of 4:00 PM EDT. Market closed.